Cargando…

Erianin: A Direct NLRP3 Inhibitor With Remarkable Anti-Inflammatory Activity

Erianin (Eri) is the extract of Dendrobium chrysotoxum Lindl. The NLRP3 inflammasome is a multiprotein complex that plays key roles in a wide variety of chronic inflammation-driven human diseases. Nevertheless, little is known about the protection of Eri against NLRP3 inflammasome-related diseases....

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xinyong, Hu, Lei, Xu, Shilei, Ye, Chao, Chen, Aidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564113/ https://www.ncbi.nlm.nih.gov/pubmed/34745110 http://dx.doi.org/10.3389/fimmu.2021.739953

Ejemplares similares

The roles of ERIANIN in tumor and innate immunity and its’ perspectives in immunotherapy
por: Yang, Zhen, et al.
Publicado: (2023)

Erianin: A phytoestrogen with therapeutic potential
por: Li, Gangmin, et al.
Publicado: (2023)

NLRP3 Inflammasome and Inflammatory Bowel Disease
por: Zhen, Yu, et al.
Publicado: (2019)

Progressive study of effects of erianin on anticancer activity
por: Zhang, Yuying, et al.
Publicado: (2019)

Pharmacological Inhibitors of the NLRP3 Inflammasome
por: Zahid, Ayesha, et al.
Publicado: (2019)

The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors
por: Zhan, Xiaoyan, et al.
Publicado: (2023)

Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
por: Jiang, Hua, et al.
Publicado: (2017)

Piperlongumine Is an NLRP3 Inhibitor With Anti-inflammatory Activity
por: Shi, Jie, et al.
Publicado: (2022)

NLRP3+ macrophages aggravate inflammatory cystitis in diabetes
por: Peng, Yubing, et al.
Publicado: (2022)

Repositioning of the Angiotensin II Receptor Antagonist Candesartan as an Anti-Inflammatory Agent With NLRP3 Inflammasome Inhibitory Activity
por: Lin, Wen-Yu, et al.
Publicado: (2022)

Ceramide Regulates Anti-Tumor Mechanisms of Erianin in Androgen-Sensitive and Castration-Resistant Prostate Cancers
por: Trapika, I Gusti Md Gde Surya C., et al.
Publicado: (2021)

Erianin against Staphylococcus aureus Infection via Inhibiting Sortase A
por: Ouyang, Ping, et al.
Publicado: (2018)

The anti-carcinogenesis properties of erianin in the modulation of oxidative stress-mediated apoptosis and immune response in liver cancer
por: Zhang, Xinrui, et al.
Publicado: (2019)

Regulatory Mechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker in Cardiovascular Diseases
por: An, Na, et al.
Publicado: (2019)

Dual Targeting of Cell Growth and Phagocytosis by Erianin for Human Colorectal Cancer
por: Sun, Yihan, et al.
Publicado: (2020)

The Role of NLRP3 and IL-1β in the Pathogenesis of Inflammatory Bowel Disease
por: Mao, Liming, et al.
Publicado: (2018)

NLRP3 Sensing of Diverse Inflammatory Stimuli Requires Distinct Structural Features
por: Rahman, Tabassum, et al.
Publicado: (2020)

The NLRP3 Inflammasome Inhibitor Dapansutrile Attenuates Cyclophosphamide-Induced Interstitial Cystitis
por: Kiran, Sonia, et al.
Publicado: (2022)

The landscape of mitophagy in sepsis reveals PHB1 as an NLRP3 inflammasome inhibitor
por: Chen, Shipeng, et al.
Publicado: (2023)

Megakaryocyte NLRP3 hyperactivation induces mild anemia and potentiates inflammatory response in mice
por: Bourne, Joshua H., et al.
Publicado: (2023)

The effect of tai chi intervention on NLRP3 and its related antiviral inflammatory factors in the serum of patients with pre-diabetes
por: Hu, Shujuan, et al.
Publicado: (2022)

NLRP3, NLRP12, and IFI16 Inflammasomes Induction and Caspase-1 Activation Triggered by Virulent HSV-1 Strains Are Associated With Severe Corneal Inflammatory Herpetic Disease
por: Coulon, Pierre-Gregoire, et al.
Publicado: (2019)

Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway
por: Xu, Yonggang, et al.
Publicado: (2021)

Transferrin-Conjugated Erianin-Loaded Liposomes Suppress the Growth of Liver Cancer by Modulating Oxidative Stress
por: Yang, Anhui, et al.
Publicado: (2021)

Anticancer Activity of Erianin: Cancer-Specific Target Prediction Based on Network Pharmacology
por: Yan, Lili, et al.
Publicado: (2022)

Identification of NLRP3(PYD) Homo-Oligomerization Inhibitors with Anti-Inflammatory Activity
por: Moasses Ghafary, Soroush, et al.
Publicado: (2022)

BRD4 Inhibition Attenuates Inflammatory Pain by Ameliorating NLRP3 Inflammasome-Induced Pyroptosis
por: Hua, Tong, et al.
Publicado: (2022)

PPT1 Reduction Contributes to Erianin-Induced Growth Inhibition in Oral Squamous Carcinoma Cells
por: Luo, Qingqiong, et al.
Publicado: (2021)

The Role of HDAC6 in Autophagy and NLRP3 Inflammasome
por: Chang, Panpan, et al.
Publicado: (2021)

NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: From cryopyrin function to targeted therapies
por: Moltrasio, Chiara, et al.
Publicado: (2022)

Relevance of the NLRP3 Inflammasome in the Pathogenesis of Chronic Liver Disease
por: Wu, Xiaoqin, et al.
Publicado: (2017)

ATP Facilitates Staphylococcal Enterotoxin O Induced Neutrophil IL-1β Secretion via NLRP3 Inflammasome Dependent Pathways
por: Hou, Fengqing, et al.
Publicado: (2021)

Erianin alleviates collagen-induced arthritis in mice by inhibiting Th17 cell differentiation
por: Tsai, Sen-Wei, et al.
Publicado: (2023)

Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2
por: Wang, Penglei, et al.
Publicado: (2023)

Regulation of NLRP3 Inflammasome by Phosphorylation
por: Song, Nan, et al.
Publicado: (2018)

Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023)

Electroacupuncture Inhibits NLRP3 Activation by Regulating CMPK2 After Spinal Cord Injury
por: Chen, Yi, et al.
Publicado: (2022)

Tivantinib alleviates inflammatory diseases by directly targeting NLRP3
por: Huang, Yi, et al.
Publicado: (2023)

Diabetes Mellitus Promotes the Development of Atherosclerosis: The Role of NLRP3
por: Ye, Jingxue, et al.
Publicado: (2022)

DDX3X Links NLRP11 to the Regulation of Type I Interferon Responses and NLRP3 Inflammasome Activation
por: Kienes, Ioannis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gbtcip1es51luilrgolmk0n1fi